Anti‑tumor activity of bee pollen

As a natural complex of bioactive substances, the anti-tumor potential of bee pollen is increasingly being revealed by scientific research. Current evidence indicates that components such as polysaccharides and peptides in bee pollen exert dual effects-direct tumor inhibition and systemic immune regulation-through multi-target, multi-pathway synergistic actions, demonstrating promising prospects as an adjuvant anti-tumor agent.

I. Core Anti‑tumor Mechanisms of the Polysaccharide Fraction

Research on the anti-tumor effects of bee pollen has focused heavily on its polysaccharide components. A large number of in vitro and in vivo studies have confirmed that bee pollen polysaccharides act through two pathways: direct inhibition and immune modulation.

1. Direct inhibition of tumor cell proliferation

Multiple studies have directly demonstrated the cytotoxicity of bee pollen polysaccharides against tumor cell lines. Wang et al. (2013) found that bee pollen polysaccharides significantly inhibited the proliferation of human colorectal cancer cell lines HCT116 and HT29. A further in-depth study by Wang Bo (2013) refined this finding: using the MTT assay on various bee pollen polysaccharide fractions, the anti-tumor activity was confirmed to be concentration-dependent, with the neutral sugar fraction showing particularly strong inhibitory effects. This indicates that the structural characteristics of the polysaccharides are closely related to their biological activity.

2. Potent immune modulation and systemic activation

An even more notable action of bee pollen polysaccharides is their systemic immune-activating ability, which is a key mechanism underlying their in vivo anti-tumor effect.

Enhancement of immune organ and cell function: A classic study by Yang et al. (2007) showed that rape bee pollen polysaccharides significantly increased natural killer (NK) cell activity, monocyte phagocytic function, and lymphocyte proliferation in tumor‑bearing mice, as well as increased the relative weights of the spleen and thymus, thereby strengthening both the “hardware” and “software” of the immune system.

Regulation of the cytokine network: Bee pollen polysaccharides can subtly modulate the body's complex cytokine balance, thereby inhibiting the tumor‑promoting environment. Studies by Yang Xiaoping et al. (2005; 2008) indicated that rape bee pollen polysaccharides act by upregulating the mRNA expression of interleukin-2 (IL-2) and tumor necrosis factor (TNF) in spleen cells. Research on safflower bee pollen polysaccharides provides a more detailed picture: Chen Luyan et al. (2019) and Chu Shanshan et al. (2019) both showed that different polysaccharide fractions (PBPCI and PBPCII) can raise the levels of pro-immune/anti-tumor cytokines such as IL-2, interferon-γ(IFN-γ), and TNF-α, while simultaneously reducing the levels of pro‑inflammatory and pro-angiogenic factors such as interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF). This reshapes the tumor microenvironment and inhibits tumor growth and spread.

Mediation of anti-angiogenic effects: The reduction in VEGF levels mentioned above suggests that bee pollen polysaccharides may also act through an anti-angiogenic pathway, cutting off the tumor's nutrient supply -a mechanism consistent with the "anti-angiogenic action" proposed by Yang et al. (2007).

II. Contributions of Peptides and Other Active Components

Besides polysaccharides, other active components in bee pollen also play important roles.

Immune activity of peptides: Xu Jiaxi et al. (1997) isolated several peptides from rape and poppy bee pollen and confirmed that they possess good anti-tumor immune activity, providing further evidence for the "multi-component synergy" theory of bee pollen's anti-tumor action.

Steroid‑induced apoptosis: A study by Wu et al. (2007) revealed the direct anti-cancer mechanism of the steroid fraction from rape bee pollen. This fraction induced apoptosis in several cancer cell lines, including prostate cancer PC-3 cells. The mechanism involved activation of caspase-3 and downregulation of Bcl-2 protein expression, thereby initiating the programmed cell death pathway.

III. Safety and Adjuvant Therapeutic Potential

A prominent highlight of research on bee pollen's anti-tumor effects is its excellent safety profile, which lays the foundation for its use as a functional adjuvant.

Low toxicity and side effects: Yang Xiaoping et al. (2006) showed that rape bee pollen polysaccharides had no obvious toxic effects on vital organs (liver, kidney, spleen, thymus) of tumor-bearing mice.

Toxicity reduction, sensitivity enhancement, and organ protection: The same study also found that when bee pollen polysaccharides were used in combination with the classic chemotherapeutic drug cyclophosphamide, they not only enhanced the anti-tumor effect but also alleviated cyclophosphamide‑induced liver damage, ameliorated chemotherapy‑induced anemia and peripheral blood abnormalities (Yang et al., 2007). This highlights the great potential of bee pollen in comprehensive cancer therapy for "reducing toxicity and increasing sensitivity"-i.e., alleviating the side effects of radiotherapy/chemotherapy while improving treatment efficacy.

Summary 

Current research systematically reveals the multi-level mechanisms of action of bee pollen polysaccharides and peptides in anti-tumor processes, including direct cytotoxicity, immune system activation, cytokine network regulation, and chemo-adjuvant protection. These findings provide an important theoretical basis for the application of bee pollen in tumor nutritional intervention and adjuvant therapy. Future studies need to further clarify its structure-activity relationship, metabolic fate in the human body, and clinical efficacy, in order to promote the translation of bee pollen from experimental research to standardized clinical application.

Reference

1. Chen, L. Y., Chu, S. S., & Zuo, S. Y. (2019). Anti-tumor effect of polysaccharide I from safflower bee pollen on H22 tumor-bearing mice. Asia-Pacific Traditional Medicine, 15(6), 9-12.
2. Chu, S. S. (2019). Study on the anti-tumor activity and mechanism of polysaccharide component PBPCII from Yunnan safflower bee pollen (Master’s thesis). Dali University, Dali, China.
3. WANG Bo, ZHANG Meng-shan, ZHANG Zhong-yu, et al. Antitumor activity of bee pollen polysaccharides from Rosa rugosa[J]. Molecular medicine reports, 2013 (5):1555-1558.
4. Wang, B. (2013). Analysis and anti-tumor activity of polysaccharides from eight kinds of bee pollen (Master’s thesis). Northeast Normal University, Changchun, China.
5. WU Y D, LOU Y J. Asteroid fraction of chloroform extract from bee pollen of Brassica campestris induces apoptosis in human prostate cancer PC-3 cells [J]. Phytotherapy Research, 2007, 21(11):1 087-1 091.
6. Xu, J. X., & Jin, S. (1997). Synthesis of analogs and fragments of heptadecapeptide from poppy pollen and their anti-tumor activity. Chemical Journal of Chinese Universities, 18(7), 5. [Note: Page number”5”may be the starting page; if exact range is needed, please check original.]
7. YANG Xiao-ping, GUO Da-yong, ZHANG Jin-ming, et al.Characterization and anti-tumor activity of pollen polysaccharide[J]. International Immunopharmacology, 2007, 7(3):401-408.
8. Yang, X. P., & Wu, M. C. (2006). Study on anti-tumor effect of rape bee pollen polysaccharide. Acta Nutrimenta Sinica, 28(2), 160-162, 166.
9. Yang, X. P., & Wu, M. C. (2008). Effect of rape pollen polysaccharide on IL-2, TNFα production and their mRNA expression in splenocytes of tumor-bearing mice. Scientia Agricultura Sinica, 41(1), 182-187.
10. Yang, X. P., Luo, Z. Y., Wu, M. C., et al. (2005). Preparation of rape pollen polysaccharide and its effect on tumor-bearing mice. Food Science, 26(12), 202-204.